Prospective observational study to evaluate the efficacy and safety of PD-1/PD-L1 antibody by PK/PD/PGx analysis.
Not Applicable
- Conditions
- ung Cancer
- Registration Number
- JPRN-UMIN000029994
- Lead Sponsor
- ational Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 210
Inclusion Criteria
Not provided
Exclusion Criteria
Not applicable
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response Rate
- Secondary Outcome Measures
Name Time Method